Discontinued — last reported Q4 '23
Pharma Solutions — D&A
International Flavors & Fragrances Pharma Solutions — D&A remained flat by 0.0% to $34.25M in Q4 2023 compared to the prior quarter. Year-over-year, this metric declined by 1.4%, from $34.75M to $34.25M. Over 2 years (FY 2021 to FY 2023), Pharma Solutions — D&A shows relatively stable performance with a 4.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
High levels relative to revenue suggest a capital-intensive business model, while low levels suggest a more asset-light operation.
Detailed definition
The non-cash expense allocated to the Pharma Solutions segment to account for the wear and tear of tangible assets and t...
Peer comparison
Standard operating expense metric across all manufacturing and industrial sectors.
iff_segment_pharma_solutions_depreciation_and_amortizationHistorical Data
| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $125.00M | $139.00M | $137.00M |
| YoY Change | — | +11.2% | -1.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is International Flavors & Fragrances's pharma solutions — d&a?
- International Flavors & Fragrances (IFF) reported pharma solutions — d&a of $34.25M in Q4 2023.
- How has International Flavors & Fragrances's pharma solutions — d&a changed year-over-year?
- International Flavors & Fragrances's pharma solutions — d&a decreased by 1.4% year-over-year, from $34.75M to $34.25M.
- What is the long-term trend for International Flavors & Fragrances's pharma solutions — d&a?
- Over 2 years (2021 to 2023), International Flavors & Fragrances's pharma solutions — d&a has grown at a 4.7% compound annual growth rate (CAGR), from $125.00M to $137.00M.
- What does pharma solutions — d&a mean?
- The non-cash cost of using up physical assets and intangible assets over their useful lives.